Immatics at Immuno-Oncology Summit 2019 (Aug 5-9) in Boston, MA
Meet Immatics at this year’s I-O Summit and join CMO Carsten Reinhardt at the 2nd Bispecific Antibodies for Cancer Immunotherapy Conference for Immatics updates on biotherapeutics in Immuno-Oncology.
Wednesday, Aug 7, 5.15 – 5.45pm EST
Track: Engineering Bispecific and Multi-Specific Antibodies
TCER® Bispecific Molecules: TCR-Based T-cell Engaging Receptors for the Treatment of Cancer
Speaker: Carsten Reinhardt, CMO Immatics
We’re looking forward to interesting and exciting discussions.
Further information on Immuno-Oncology Summit 2019 here.